Review Article

Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers

Table 5

Altered expression of Eph receptors and ephrin ligands in prostate cancer.

Eph receptor/ephrin ligand Preferred molecular interaction↑/↓ relative to normal tissueMechanismReference

EphA1(i) Lower level of EphA1 transcript levels in primary prostate tumor cells compared to normal prostate epithelium[86]

EphA2Ephrin-A1(i) Highest levels of EphA2 staining in prostatic adenocarcinoma followed by high grade intraepithelial neoplasia with low positive EphA2 staining in benign tissue
(ii) EphA2 stimulation with ephrin-A1 resulted in inhibition of PC3 migration
[87, 88]

EphA3(i) Increase level of EphA3 in androgen independent prostate cancer cells compared to androgen dependent prostate cancer cells
(ii) Inactivation of AMP-activated protein kinase (AMPK) resulted in transformation of prostate cancer cell line and upregulation of EphA3 mRNA
[89, 90]

EphA4Ephrin-A5(i) cDNA microarray shows EphA4 elevation in prostatic intraepithelial neoplasia and prostate cancer
  (1) SiRNA knockout of EphA4 resulted in decrease cell viability and colony formation
(ii) EphA4 stimulation with ephrin-A5 resulted in inhibition of PC3 migration
(iii) EphA4 may be regulated by ERBB3/HER3
  (1) Knockdown of ERBB3 in DU-145 resulted in downregulation of EphA4
[88, 91, 92]

EphB2Mutant expression of inactive EphB2 in prostate cancer(i) Two mutations in extracellular part of EphB2 and six mutations in the intracellular part of EphB2
  (1) Extracellular mutation: R199H, A279S
  (2) Intracellular mutation: D679N, 2139+2T→C, Q723X, T909M, K1019X, and 3051delA
(ii) Loss of EphB2 in primary prostate tumor cells compared to normal prostate epithelium cells
[86, 93]

Ephrin-A1(i) Higher Gleason score correlate with lower levels of ephrin-A1[94]

Ephrin-A5EphA4 
EphA7 
EphB1 
EphB2
(i) Proteomic analysis of LnCaP cell culture media demonstrated increased levels of ephrin-A5 post androgen exposure
(ii) Lower levels of ephin-A5 correlated with shorter predicated survival time
[95, 96]